Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00416962 · ClinicalTrials.gov registry record · Phase 1
Safety and Pharmacokinetic Effects of Oseltamivir Alone or in Combination With Amantadine
A Phase 1 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT00416962 is a Phase 1 study that has completed, run by Novartis. The registered enrollment target is 18 participants.
The verdict
NCT00416962, a Phase 1 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
This study is designed to assess the safety and pharmacokinetic effects of oseltamivir administration alone or in combination with amantadine in healthy volunteers.
Interventions
- DRUG amantadine hydrochloride
- DRUG oseltamivir phosphate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2006-08 |
| Est. Completion | 2006-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00416962
The ClinicalTrials.gov registry entry for NCT00416962 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which amantadine hydrochloride is the first listed.
NCT00416962 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00416962 about?
NCT00416962 is a clinical study titled "Safety and Pharmacokinetic Effects of Oseltamivir Alone or in Combination With Amantadine". This study is designed to assess the safety and pharmacokinetic effects of oseltamivir administration alone or in combination with amantadine in healthy volunteers.
What is the current status of trial NCT00416962?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2006-08. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00416962?
The interventions under investigation include: amantadine hydrochloride (DRUG), oseltamivir phosphate (DRUG).
Who is sponsoring clinical trial NCT00416962?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.